Skip Main Navigation

Download Conference Programmme

Reading Room
Find articles about healthcare-associated infection published in The Lancet journals

Go to The Lancet Conferences Homepage

Reading Room

Read The Lancet Infectious Diseases Leading Edge, October 2008 (PDF, 113kb)

Other resources:
Articles on healthcare-associated infections
Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008; 8: 289-301.
Anon. MRSA: how politicians are missing the point. Lancet 2005; 365: 1203.
Anon. The traditional white coat: goodbye, or au revoir? Lancet 2007; 370: 1102.
Anon. MRSA: moving beyond mops and matrons. Lancet 2007; 370: 362.
Anon. Hospital hygiene sweeps resistance under the carpet. Lancet Infect Dis 2004; 4: 713.
Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005; 5: 549-57.
Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 1819-1827.
Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314-25.
Boyce JM, Cookson B, Christiansen K, et al. Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005; 5: 653-663.
Bradley JS, Guidos R, Baragona S, et al. Anti-infective research and development--problems, challenges, and solutions. Lancet Infect Dis 2007; 7: 68-78.
Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005; 365: 295-304.
Chopra I, Schofield C, Everett M, et al. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 2008; 8: 133-39.
Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 2008; 8: 101-13.
de Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362: 1011-16.
Eggimann P, Harbarth S, Constantin MN , Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-68.
Farr BM, Salgado CD, Karchmer TB, Sherertz RJ. Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect Dis 2001; 1: 38-45.
Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis 2006; 6: 426-37.
Gould IM. Community-acquired MRSA: can we control it? Lancet 2006; 368: 824-26.
Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-85.
Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-155.
Huskins WC, Goldmann DA. Controlling meticillin-resistant Staphylococcus aureus, aka "Superbug". Lancet 2005; 365: 273-75.
Jones A, Morgan D, Walsh A, et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006; 6: 317-18.
Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001; 357: 1225-1240.
Orendi J. Health-care organisation, hospital-bed occupancy, and MRSA. Lancet 2008; 371: 1401-02.
Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006; 6: 753-55.
Nickerson EK, Wuthiekanun V, Day NP, Chaowagul W, Peacock SJ. Meticillin-resistant Staphylococcus aureus in rural Asia. Lancet Infect Dis 2006; 6: 70-71.
Norén T. Outbreak from a high-toxin intruder: Clostridium difficile. Lancet 2005; 366: 1053-54.
Pitout JD, Laupland KB. Extended-spectrum ß-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.
Pittet D, Donaldson L. Clean Care is Safer Care: a worldwide priority. Lancet 2005; 366: 1246-47.
Pittet D, Allegranzi B, Sax H, et al. Considerations for a WHO European strategy on health-care-associated infection, surveillance, and control. Lancet Infect Dis 2005; 5: 242-50.
Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356: 1307-12.
Posfay-Barbe KM, Zerr DM, Pittet D. Infection control in paediatrics. Lancet Infect Dis 2008; 8: 19-31.
Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005; 365: 1256-1258.
Sabria M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect Dis 2002; 2: 368-373.
Tucker J; UK Neonatal Staffing Study Group. Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation. Lancet 2002; 359: 99-107.
Vandenbroucke-Grauls CM. Clean hands closer to the bedside. Lancet 2000; 356: 1290-91.
Vaudaux P, Schrenzel J. Nosocomial bacteraemia caused by Staphylococcus aureus. Lancet 2004; 364: 644-45.
Vincent J L. Selective digestive decontamination: for everyone, everywhere? Lancet 2003; 362: 1006-07.
Vincent J L. Nosocomial infections in adult intensive-care units. Lancet 2003; 361: 2068-77.
Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-84.
Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364: 703-05.

Institutes/professional bodies/useful websites
The National Institute for Occupational Safety and Health
European Centre for Disease Control and Prevention
Centers for Disease Control and Prevention
European Society of Clinical Microbiology and Infectious Diseases
National Patient Safety Agency
VMSZorg
The Health Foundation
NICE
International Society for Infectious Diseases
Infections Disease Society of America
The Lancet Infectious Diseases
The Lancet
Infection Control Today Magazine
The Journal of Infectious Diseases
Clinical Infectious Diseases
Current Infectious Disease Reports
Communicable Disease Surveillance Centre Northern Ireland
London Health Observatory
Health Protection Agency
Safe Care Campaign
Clostridium Difficile Support
mRSA Support


Carbon Footprint
Get more information on measuring and reducing your carbon footprint.

For further reading see:
Churchill LR. Bioethics beyond the lifespan. Lancet 2008; 371: 1066-67.
Markandya A, Wilkinson P. Electricity generation and health. Lancet 2007; 370: 979-90.
Wilkinson P, Smith KR, Joffe M, Haines A. A global perspective on energy: health effects and injustices. Lancet 2007; 370: 965-78.

Advertisement